BILIRUBIN (DIRECT) DICLOROFENILDIAZONIO BIOSYSTEMS
Mexico·Clase I·III. DIAGNOSTIC AGENTS·BIO SIMEX, S.A. DE C.V.·Registered September 27, 2019REACTIVO PARA LA MEDICIÓN DE LA CONCENTRACIÓN DE BILIRRUBINA DIRECTA EN SUERO O PLASMA HUMANO.
REAGENT FOR MEASURING THE CONCENTRATION OF DIRECT BILIRUBIN IN HUMAN SERUM OR PLASMA.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETERMINACIÓN DE BILIRRUBINA DIRECTA
- Trade Name (English)
- REAGENT FOR THE DETERMINATION OF DIRECT BILIRUBIN
- Analysis ID
- 1921R2019 SSA
- Registration Date
- September 27, 2019
- Name (Spanish)
- BIO SIMEX, S.A. DE C.V.
- Name (English)
- BIO SIMEX, S.A. DE C.V.
Access comprehensive regulatory information for BILIRUBIN (DIRECT) DICLOROFENILDIAZONIO BIOSYSTEMS (BILIRUBIN (DIRECT) DICLOROFENILDIAZONIO BIOSYSTEMS) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1921R2019 SSA and manufactured by BIO SIMEX, S.A. DE C.V.. The device was registered on September 27, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.